Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Amortization of Deferred Charges (2019 - 2024)

Historic Amortization of Deferred Charges for SRx Health Solutions (SRXH) over the last 6 years, with Q2 2024 value amounting to $113000.0.

  • SRx Health Solutions' Amortization of Deferred Charges fell 1374.05% to $113000.0 in Q2 2024 from the same period last year, while for Sep 2024 it was $327000.0, marking a year-over-year increase of 9235.29%. This contributed to the annual value of $254000.0 for FY2023, which is 8790.48% down from last year.
  • According to the latest figures from Q2 2024, SRx Health Solutions' Amortization of Deferred Charges is $113000.0, which was down 1374.05% from $125000.0 recorded in Q1 2024.
  • SRx Health Solutions' 5-year Amortization of Deferred Charges high stood at $2.1 million for Q3 2022, and its period low was $5000.0 during Q4 2022.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $131000.0 (2023), whereas its average is $508588.2.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 2576250.0% in 2022, then plummeted by 9927.5% in 2023.
  • Quarter analysis of 5 years shows SRx Health Solutions' Amortization of Deferred Charges stood at $1.2 million in 2020, then plummeted by 77.08% to $264000.0 in 2021, then tumbled by 98.11% to $5000.0 in 2022, then soared by 1680.0% to $89000.0 in 2023, then grew by 26.97% to $113000.0 in 2024.
  • Its last three reported values are $113000.0 in Q2 2024, $125000.0 for Q1 2024, and $89000.0 during Q4 2023.